Revenue recognition change
beta
Filing comparison
Verastem, Inc. changed its revenue recognition disclosure
(iii) determine the F-15 Table of Contents transaction price;
Evidence
- New language
- (iii) determine the F-15 Table of Contents transaction price;, Product Revenue, Net - The Company sells AVMAPKI FAKZYNJA CO-PACK to a limited number of specialty pharmacies and specialty distributors in the United States.
- Prior filed
- 2025-03-20
- Prior form
- 10-K
- Similarity
- 0.305
- Source
- revenue recognition note comparison
- Threshold
- 0.6
- Why
- The revenue recognition policy disclosure changed materially from the previous comparable filing.
Language present now, absent from the prior filing:
- (iii) determine the F-15 Table of Contents transaction price;
- Product Revenue, Net - The Company sells AVMAPKI FAKZYNJA CO-PACK to a limited number of specialty pharmacies and specialty distributors in the United States.